Report cover image

Global Hydroxyprogesterone Caproate Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 109 Pages
SKU # APRC20340709

Description

Summary

According to APO Research, The global Hydroxyprogesterone Caproate market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Hydroxyprogesterone Caproate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Hydroxyprogesterone Caproate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Hydroxyprogesterone Caproate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Hydroxyprogesterone Caproate include Zhejiang Xianju Pharmaceutical, Mylan Institutional, Upjohn Co, Symbiotec Pharmalab, Sun Pharmaceutical, Steroid Spa, Schering Ag, Naari Ag and Mcguff Pharmaceuticals Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hydroxyprogesterone Caproate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyprogesterone Caproate.

The Hydroxyprogesterone Caproate market size, estimations, and forecasts are provided in terms of sales volume (W Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hydroxyprogesterone Caproate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Hydroxyprogesterone Caproate Segment by Company

Zhejiang Xianju Pharmaceutical
Mylan Institutional
Upjohn Co
Symbiotec Pharmalab
Sun Pharmaceutical
Steroid Spa
Schering Ag
Naari Ag
Mcguff Pharmaceuticals Inc
Diosynth Bv
Aspen Oss B.V.
Antibioticos Spa
ANI Pharmaceuticals, Inc.
AMAG Pharmaceuticals
Hydroxyprogesterone Caproate Segment by Type

1 mL Injection(Including 1.1 mL)
5 mL Injection
Hydroxyprogesterone Caproate Segment by Application

Hospitals Injection
Clinics Injection
Hydroxyprogesterone Caproate Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hydroxyprogesterone Caproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

109 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Hydroxyprogesterone Caproate Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Hydroxyprogesterone Caproate Sales Estimates and Forecasts (2020-2031)
1.3 Hydroxyprogesterone Caproate Market by Type
1.3.1 1 mL Injection(Including 1.1 mL)
1.3.2 5 mL Injection
1.4 Global Hydroxyprogesterone Caproate Market Size by Type
1.4.1 Global Hydroxyprogesterone Caproate Market Size Overview by Type (2020-2031)
1.4.2 Global Hydroxyprogesterone Caproate Historic Market Size Review by Type (2020-2025)
1.4.3 Global Hydroxyprogesterone Caproate Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Hydroxyprogesterone Caproate Sales Breakdown by Type (2020-2025)
1.5.2 Europe Hydroxyprogesterone Caproate Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Hydroxyprogesterone Caproate Sales Breakdown by Type (2020-2025)
1.5.4 South America Hydroxyprogesterone Caproate Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Hydroxyprogesterone Caproate Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Hydroxyprogesterone Caproate Industry Trends
2.2 Hydroxyprogesterone Caproate Industry Drivers
2.3 Hydroxyprogesterone Caproate Industry Opportunities and Challenges
2.4 Hydroxyprogesterone Caproate Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Hydroxyprogesterone Caproate Revenue (2020-2025)
3.2 Global Top Players by Hydroxyprogesterone Caproate Sales (2020-2025)
3.3 Global Top Players by Hydroxyprogesterone Caproate Price (2020-2025)
3.4 Global Hydroxyprogesterone Caproate Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Hydroxyprogesterone Caproate Major Company Production Sites & Headquarters
3.6 Global Hydroxyprogesterone Caproate Company, Product Type & Application
3.7 Global Hydroxyprogesterone Caproate Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Hydroxyprogesterone Caproate Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hydroxyprogesterone Caproate Players Market Share by Revenue in 2024
3.8.3 2023 Hydroxyprogesterone Caproate Tier 1, Tier 2, and Tier 3
4 Hydroxyprogesterone Caproate Regional Status and Outlook
4.1 Global Hydroxyprogesterone Caproate Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Hydroxyprogesterone Caproate Historic Market Size by Region
4.2.1 Global Hydroxyprogesterone Caproate Sales in Volume by Region (2020-2025)
4.2.2 Global Hydroxyprogesterone Caproate Sales in Value by Region (2020-2025)
4.2.3 Global Hydroxyprogesterone Caproate Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Hydroxyprogesterone Caproate Forecasted Market Size by Region
4.3.1 Global Hydroxyprogesterone Caproate Sales in Volume by Region (2026-2031)
4.3.2 Global Hydroxyprogesterone Caproate Sales in Value by Region (2026-2031)
4.3.3 Global Hydroxyprogesterone Caproate Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Hydroxyprogesterone Caproate by Application
5.1 Hydroxyprogesterone Caproate Market by Application
5.1.1 Hospitals Injection
5.1.2 Clinics Injection
5.2 Global Hydroxyprogesterone Caproate Market Size by Application
5.2.1 Global Hydroxyprogesterone Caproate Market Size Overview by Application (2020-2031)
5.2.2 Global Hydroxyprogesterone Caproate Historic Market Size Review by Application (2020-2025)
5.2.3 Global Hydroxyprogesterone Caproate Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Hydroxyprogesterone Caproate Sales Breakdown by Application (2020-2025)
5.3.2 Europe Hydroxyprogesterone Caproate Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Hydroxyprogesterone Caproate Sales Breakdown by Application (2020-2025)
5.3.4 South America Hydroxyprogesterone Caproate Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Hydroxyprogesterone Caproate Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Zhejiang Xianju Pharmaceutical
6.1.1 Zhejiang Xianju Pharmaceutical Comapny Information
6.1.2 Zhejiang Xianju Pharmaceutical Business Overview
6.1.3 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
6.2 Mylan Institutional
6.2.1 Mylan Institutional Comapny Information
6.2.2 Mylan Institutional Business Overview
6.2.3 Mylan Institutional Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Institutional Hydroxyprogesterone Caproate Product Portfolio
6.2.5 Mylan Institutional Recent Developments
6.3 Upjohn Co
6.3.1 Upjohn Co Comapny Information
6.3.2 Upjohn Co Business Overview
6.3.3 Upjohn Co Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Upjohn Co Hydroxyprogesterone Caproate Product Portfolio
6.3.5 Upjohn Co Recent Developments
6.4 Symbiotec Pharmalab
6.4.1 Symbiotec Pharmalab Comapny Information
6.4.2 Symbiotec Pharmalab Business Overview
6.4.3 Symbiotec Pharmalab Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Symbiotec Pharmalab Hydroxyprogesterone Caproate Product Portfolio
6.4.5 Symbiotec Pharmalab Recent Developments
6.5 Sun Pharmaceutical
6.5.1 Sun Pharmaceutical Comapny Information
6.5.2 Sun Pharmaceutical Business Overview
6.5.3 Sun Pharmaceutical Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sun Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
6.5.5 Sun Pharmaceutical Recent Developments
6.6 Steroid Spa
6.6.1 Steroid Spa Comapny Information
6.6.2 Steroid Spa Business Overview
6.6.3 Steroid Spa Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Steroid Spa Hydroxyprogesterone Caproate Product Portfolio
6.6.5 Steroid Spa Recent Developments
6.7 Schering Ag
6.7.1 Schering Ag Comapny Information
6.7.2 Schering Ag Business Overview
6.7.3 Schering Ag Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Schering Ag Hydroxyprogesterone Caproate Product Portfolio
6.7.5 Schering Ag Recent Developments
6.8 Naari Ag
6.8.1 Naari Ag Comapny Information
6.8.2 Naari Ag Business Overview
6.8.3 Naari Ag Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Naari Ag Hydroxyprogesterone Caproate Product Portfolio
6.8.5 Naari Ag Recent Developments
6.9 Mcguff Pharmaceuticals Inc
6.9.1 Mcguff Pharmaceuticals Inc Comapny Information
6.9.2 Mcguff Pharmaceuticals Inc Business Overview
6.9.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Product Portfolio
6.9.5 Mcguff Pharmaceuticals Inc Recent Developments
6.10 Diosynth Bv
6.10.1 Diosynth Bv Comapny Information
6.10.2 Diosynth Bv Business Overview
6.10.3 Diosynth Bv Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Diosynth Bv Hydroxyprogesterone Caproate Product Portfolio
6.10.5 Diosynth Bv Recent Developments
6.11 Aspen Oss B.V.
6.11.1 Aspen Oss B.V. Comapny Information
6.11.2 Aspen Oss B.V. Business Overview
6.11.3 Aspen Oss B.V. Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aspen Oss B.V. Hydroxyprogesterone Caproate Product Portfolio
6.11.5 Aspen Oss B.V. Recent Developments
6.12 Antibioticos Spa
6.12.1 Antibioticos Spa Comapny Information
6.12.2 Antibioticos Spa Business Overview
6.12.3 Antibioticos Spa Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Antibioticos Spa Hydroxyprogesterone Caproate Product Portfolio
6.12.5 Antibioticos Spa Recent Developments
6.13 ANI Pharmaceuticals, Inc.
6.13.1 ANI Pharmaceuticals, Inc. Comapny Information
6.13.2 ANI Pharmaceuticals, Inc. Business Overview
6.13.3 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Product Portfolio
6.13.5 ANI Pharmaceuticals, Inc. Recent Developments
6.14 AMAG Pharmaceuticals
6.14.1 AMAG Pharmaceuticals Comapny Information
6.14.2 AMAG Pharmaceuticals Business Overview
6.14.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2020-2025)
6.14.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Product Portfolio
6.14.5 AMAG Pharmaceuticals Recent Developments
7 North America by Country
7.1 North America Hydroxyprogesterone Caproate Sales by Country
7.1.1 North America Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Hydroxyprogesterone Caproate Sales by Country (2020-2025)
7.1.3 North America Hydroxyprogesterone Caproate Sales Forecast by Country (2026-2031)
7.2 North America Hydroxyprogesterone Caproate Market Size by Country
7.2.1 North America Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Hydroxyprogesterone Caproate Market Size by Country (2020-2025)
7.2.3 North America Hydroxyprogesterone Caproate Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Hydroxyprogesterone Caproate Sales by Country
8.1.1 Europe Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Hydroxyprogesterone Caproate Sales by Country (2020-2025)
8.1.3 Europe Hydroxyprogesterone Caproate Sales Forecast by Country (2026-2031)
8.2 Europe Hydroxyprogesterone Caproate Market Size by Country
8.2.1 Europe Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Hydroxyprogesterone Caproate Market Size by Country (2020-2025)
8.2.3 Europe Hydroxyprogesterone Caproate Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Hydroxyprogesterone Caproate Sales by Country
9.1.1 Asia-Pacific Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Hydroxyprogesterone Caproate Sales by Country (2020-2025)
9.1.3 Asia-Pacific Hydroxyprogesterone Caproate Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Hydroxyprogesterone Caproate Market Size by Country
9.2.1 Asia-Pacific Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Hydroxyprogesterone Caproate Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Hydroxyprogesterone Caproate Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Hydroxyprogesterone Caproate Sales by Country
10.1.1 South America Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Hydroxyprogesterone Caproate Sales by Country (2020-2025)
10.1.3 South America Hydroxyprogesterone Caproate Sales Forecast by Country (2026-2031)
10.2 South America Hydroxyprogesterone Caproate Market Size by Country
10.2.1 South America Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Hydroxyprogesterone Caproate Market Size by Country (2020-2025)
10.2.3 South America Hydroxyprogesterone Caproate Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Hydroxyprogesterone Caproate Sales by Country
11.1.1 Middle East and Africa Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Hydroxyprogesterone Caproate Sales by Country (2020-2025)
11.1.3 Middle East and Africa Hydroxyprogesterone Caproate Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Hydroxyprogesterone Caproate Market Size by Country
11.2.1 Middle East and Africa Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Hydroxyprogesterone Caproate Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Hydroxyprogesterone Caproate Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Hydroxyprogesterone Caproate Value Chain Analysis
12.1.1 Hydroxyprogesterone Caproate Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Hydroxyprogesterone Caproate Production Mode & Process
12.2 Hydroxyprogesterone Caproate Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Hydroxyprogesterone Caproate Distributors
12.2.3 Hydroxyprogesterone Caproate Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.